Environmental
Social
Governance

Governance

Jeong-Do Management

Dong-A Socio Group is doing its best to practice Jeong-do management, the group's management philosophy.

Jeong-Do Management 1.
CEO Message

A message from our CEO

The word ‘Trust’ comes from the German term ‘Trust’ which means comfort. We feel comfortable when we trust each other. We can have reliable relationships with our partners to make things right for them.

‘Trust’ is closely linked to our Jeongdo Management(JM) principle, our Corporate Social Responsibility(CSR). Through JM principle, we are committed to providing mutual benefits and encouraging trust with any of our stakeholders and society as a whole.

Since JM principle can be comprehended only if individual employees comply with our ethical instruction, policy, and procedure, I do require all the employees to abide by our Anti-Bribery Policy and all applicable Anti-Bribery laws, including the local laws in every country in which we do business.

I would like to express my heartfelt gratitude to all employees for your active participation in JM principle.

- ST PHARM CEO, Peter Kyung-jin Kim

Jeong-Do Management 2.
Anti-Corruption Policy

Anti-Corruption Policy

  1. All corruption(bribery) related to the work of ST PHARM employees is prohibited
  2. ST PHARM complies with applicable domestic anti-corruption laws and includes foreign anti-corruption laws if necessary
  3. Anti-corruption compliance function sets company-wide anti-corruption goals and implementation plans and in each sector establishes goals and implementation plans for each sector to ensure that this policy is achieved
  4. ST PHARM encourages raising any stakeholder's concerns in good faith without fear of retaliation and disadvantages or based on reliable confidence
  5. ST PHARM ensures the authority and independence of the anti-corruption compliance and ST PHARM Anti-bribery Audit Committee (STPAAC) in accordance with the detailed operating standards.
  6. ST PHARM employees must comply with this anti-corruption policy and procedures. When non-compliance, it is important to keep in mind that strict disciplinary procedures are followed by personnel procedures.
  7. This anti-corruption policy should be communicated in the appropriate language to ST PHARM employees and business associates with moderate or higher corruption risks.
  8. ST PHARM makes it possible for stakeholders related to ST PHARM to use the anti-corruption policy at any time.

General Meeting of Shareholders

  • ST PHARM ESG Report

  • 14th General Meeting of Shareholders

     

    14th Annual General Meeting of Shareholders


    1. Date 

         March 25. 2022 (9:00 a.m. KST)
     


    2. Venue

     
        ST PHARM (Banwol Campus, Auditorium)
        171 Haean-ro, Danwon-gu, Ansan-si, Gyeonggi-do, Republic of Korea


    3. Agenda


        - Matters to Report
               Audit Report, Business Report, Internal Audit Management Report
     
        - Matters to Approve

           No.1) Approval of Financial Statement & Annual Dividends (FY 2021)
                     - Annual Dividends (Cash) : 500 KRW per share
           
           No.2) Appointment of Directors
                    - Appointment of Executive Director (Hyun-Min Lee, Head of Business Management Div.)
                    - Appointment of Executive Director (Sun-Ki Chang, Head of Manufacturing Div.)
                    - Appointment of Independent Director (Dong-Pyo Kim)
           
           No.3) Approval of Stock Option Grant
                    - Approval of Stock Option Grant
                    - Approval of Employee Stock Option Grant

           No.4) Approval of Director Remuneration Limit

           No.5) Approval of Auditor Remuneration Limit